BACKGROUND This article examines the incidence of venous thromboembolism (VTE) in combat wounded, identifies risk factors for pulmonary embolism (PE), and compares the rate of PE in combat with previously reported civilian data. METHODS A retrospective review was performed of all U.S. military combat casualties in Operation Enduring Freedom and Operation Iraqi Freedom with a VTE recorded in t...

The risk of venous thromboembolism (VTE) in patients with Neuroleptic malignant syndrome (NMS) and those on antipsychotic medications is well established. We present here a case whereby the patient had NMS and developed extensive deep venous thrombosis (DVT) despite being on standard DVT Prophylaxis. Our case illustrates that empiric intravenous heparin for the initial few days after the onset ...

Venous thromboembolism (VTE) is a disease that is caused by genetic and environmental factors that interact in a dynamic, time-dependent model.1 Therefore, it is not astonishing that, although VTE is seen throughout the world, the rate of its clinical manifestations, deep venous thrombosis (DVT) and pulmonary embolism (PE), varies. Thus, Asian and Native American individuals have been reported ...

Rivaroxaban (with initial increased dosage) may be used as a stand-alone therapy in patients with venous thrombo-embolism. The development of new anticoagulant drugs opened several options in the management of venous thrombo-embolism. The efficacy and safety of these new oral anticoagulants in specific population as elderly and those with renal impairment deserve future research. At that time, ...

Forty out of 76 patients (53%) who had suffered a cerebrovascular accident developed deep venous thrombosis of the paralysed leg, as detected with the 125I-fibrinogen technique. A further five also had thrombosis in the non-paralysed leg. A study of many predisposing risk factors provided no help either in elucidating the cause of venous thromboembolism or in identifying patients at risk of DVT...

ical within the British press for some time. Dramatic headlines seem to imply that physicians frequently misdiagnose VTE with disastrous consequences. This conference explored different aspects of the difficult diagnoses of deep vein thromboses (DVT) and pulmonary emboli (PE) and how to avoid common pitfalls. The main message remains that while diagnostic tools and sensitive blood tests exist t...

Deep vein thrombosis (DVT) is a common disease seen in western hospitals! There is a great difficulty in surveying the true incidence of venous thromboembolism in a community. Most data on incidence are related to clinically recognisable cases. It is generally believed that there is a marked ethnical and geographical difference in the incidence of venous thromboembolism. Hume in 1966 estimated ...

Deep venous thrombosis and pulmonary embolism, together called venous thromboembolism, remain a serious national health problem. Estimates suggest that over 900,000 cases occur in the United States per year, with 300,000 deaths per year. Because of the significant and serious nature of this problem, a workshop was held in May of 2006, which resulted in the Acting U.S. Public Health Service Surg...

BACKGROUND Current guidelines suggest that all patients with acute deep venous thrombosis should be treated with intravenous heparin for at least 5 days, overlapping with warfarin sodium for 4 to 5 days. METHODS Using linked state of California hospital discharge records from 1991 to 1994 we identified patients with acute deep venous thrombosis without pulmonary embolism, and determined the 6...

We report a 36-year-old woman with a 1-year history of systemic lupus erythematosus who was admitted with acute onset of dyspnea and chest pain. She presented with a classic medical history of antiphospholipid antibody syndrome, including spontaneous abortion, deep venous thrombosis, and clinical manifestations of lupus activation. The differential diagnosis was made after a detailed history an...